An Unusual Location of Cloacogenic Carcinoma

International Surgery

Volumn 83, Issue 4, 1998, Pages 343-346

  Indinnimeo, M ^a   Cicchini, C ^a   Stazi, A ^a   Limiti, M R ^a   Ghini, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anal neoplasms; Diagnosis; Extra anal cloacogenic tumor; Treatment

Indexed keywords

ANUS TUMOR; ARTICLE; CASE REPORT; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; TRANSITIONAL CELL CARCINOMA;

ANUS NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MIDDLE AGED; RECTAL NEOPLASMS;

EID: 0032175872     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hermann G, Desfosses L. Sur la muquese dela region cloacale de rectum. Compt Rend Acad Sci 1880:90:1301-2.
2. Grinvalsky HT, Helwing EB. Carcinoma of anorectal junction - histological consideration. Cancer 1956;9:480-8.
3. Wittoesch JH, Woolner LB, Jackman RJ. Basal cell epithelioma and basaloid lesions of the anus. Surg Obstet Gynecol 1957:104:75-80.
4. Schechterman L. Transitional cloacogenic carcinoma. Am J Proct 1960;11:212-32.
5. Grodsky L. Transitional cell cancer of the anus and rectum. Calif Med 1961;95:386-90.
6. Klotz Jr RG, Pamukcoglu T, Souilliard DH. Transitional cloacogenic carcinoma of the anal canal. Cancer 1967;20:1727-45.
7. Kheir S, Hickey RC, Martin RG, MacKay J, Gallager HS. Cloacogenic carcinoma of the anal canal. Arch Surg 1972;104:407-15.
8. Lone F, Berg J, Stearns Jr MW. Basaloid tumors of the anus. Cancer 1960;13:907-13.
9. Davidson NGP, Yong PPL. Brain metastasis from basaloid carcinoma of the anal canal 8 years after abdominoperineal resection. Eur J Surg Oncol 1991;17:227-30.
10. Shindo K, Bacon HE. Transitional-cell cloacogenic carcinoma of the perianal region, anal canal and rectum: report of seven cases. Dis Colon Rectum 1971;14:222-5.
11. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-9.
12. Schlag PM, Hunerbein M. Anal cancer: multimodal therapy. World J Surg 1995;19:282-6.
13. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-39.
14. Gallen M, Pla J, Miguel A, Ibeas R, Carles J, Fabregat X. Anal carcinoma: a 14 year experience. Rev Esp Enferm Dig 1997;89:23-8.
15. Cola B. Ismail I, Montanari-Reggiani F, Carnali M, de Manzini N. Le cancer de l'anus. Role actuel de la chirurgie. Chirurgie 1990;116:89-98.
16. Boman BM, Moertel CG, O'Connell MJ, Scott M, Weiland LH, Beart RW et al. Carcinoma of the anal canal. A clinical study of 188 cases. Cancer 1984;54:114-25.
17. Kubota Y, Petras RE, Easley KA, Bauer TW, Tubbs RR, Fazio VW. Ki67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 1992;70:2602-9.
18. Porschen R, Lohe B, Hengels KJ, Borchard F. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki67. Correlation with pathohistologic criteria and influence of irradiation. Cancer 1989;64:2501-5.
19. Saclarides T, Speziale NJ, Drab E, Szeluga DJ, Rubin DB. Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum 1994;37:921-6.